Chunghwa Chemical Synthesis & Biotech Co Ltd (1762)

Taiwan
59.40
+1.20(+2.06%)
  • Volume:
    2,619,000
  • Bid/Ask:
    59.40/59.60
  • Day's Range:
    58.20 - 61.70

1762 Overview

Prev. Close
58.2
Day's Range
58.2 - 61.7
Revenue
1.54B
Open
60
52 wk Range
47.55 - 78.8
EPS
6.81
Volume
2,619,000
Market Cap
4.61B
Dividend (Yield)
1.50 (1.37%)
Average Vol. (3m)
2,031,852
P/E Ratio
8.54
Beta
1.14
1-Year Change
-15.65%
Shares Outstanding
77,560,000
Next Earnings Date
Jun 02, 2021
What is your sentiment on Chunghwa Chemical Synthesis & Biotech Co Ltd?
or
Market is currently closed. Voting is open during market hours.

Chunghwa Chemical Synthesis & Biotech Co Ltd News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellBuy
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Buy
SummaryStrong SellStrong SellStrong SellStrong SellStrong Buy

Chunghwa Chemical Synthesis & Biotech Co Ltd Company Profile

Chunghwa Chemical Synthesis & Biotech Co Ltd Company Profile

Employees
243
Market
Taiwan

CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO., LTD. is a Taiwan-based company principally engaged in the manufacture and distribution of biotechnology products and chemical synthetic products. The Company's biotechnology products include pravastatin, rapamycin, tacrolimus, everolimus, mycophenolate mofetil, mycophenolic acid sodium and others. Its non-biotechnology products include methocarbamol, guaifenesin, trandolapril, fluconazole, olopatadine, dexbromopheniramine maleate and glipizide, among others. Its products are applied in the manufacture of drugs for treatment of cough, diabetes, cardiovascular diseases, high blood pressure and immune system diseases. The Company distributes its products within domestic market and to overseas markets, including the rest of Asia, the Americas and Europe.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.